EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands

V D de Jager, B N Cajiao Garcia, C C H J Kuijpers, G H de Bock, W J Maas, W Timens, L C van Kempen, A J van der Wekken, E Schuuring, S M Willems

European Journal of Cancer · 2024-07 · 205 · 114125

DOI: 10.1016/j.ejca.2024.114125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2024-07. Verfasst von V D de Jager und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsBiomarkers, TumorHumansMaleNetherlandsFemaleAgedMiddle AgedAged, 80 and overAdultGuideline Adherence

Stichwörter der Autor:innen

Guideline-adherenceNSCLCPredictive biomarker testingReal-world data

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • The Dutch Nationwide Pathology Databank (Palga), Houten, the Netherlands.
  • Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Pathology, University Hospital Antwerp, University of Antwerp, Edegem,…
  • Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: s.m.willems@umcg.nl.

Zitieren

APA

de Jager, V. D., Cajiao Garcia, B. N., Kuijpers, C. C. H. J., de Bock, G. H., Maas, W. J., Timens, W., van Kempen, L. C., van der Wekken, A. J., Schuuring, E., & Willems, S. M. (2024). Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands. European Journal of Cancer, 205, 114125. https://doi.org/10.1016/j.ejca.2024.114125

Vancouver

de Jager VD, Cajiao Garcia BN, Kuijpers CCHJ, de Bock GH, Maas WJ, Timens W, et al. Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands. European Journal of Cancer. 2024;205:114125. doi:10.1016/j.ejca.2024.114125

BibTeX
@article{deJager2024,
  author = {de Jager, V D and Cajiao Garcia, B N and Kuijpers, C C H J and de Bock, G H and Maas, W J and Timens, W and van Kempen, L C and van der Wekken, A J and Schuuring, E and Willems, S M},
  title = {Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {205},
  pages = {114125},
  doi = {10.1016/j.ejca.2024.114125}
}
Kostenlos starten →